M&A probe targets ESI CRNX SOLS PATK

2026-10-08

UBS Raises Price Target for Element Solutions Stock to USD 48

UBS raised its price target for Element Solutions to USD 48, maintaining a Buy rating after Q2 2026 revenue of USD 977.90 million beat estimates. The specialty chemicals company will report next quart

AD HOC NEWS · 2026-10-08 11:13 UTC

2026-10-05

UBS Adjusts Price Target on Element Solutions to $48 From $47, Keeps Buy Rating

UBS raised its price target for specialty chemicals firm Element Solutions to $48 from $47 while maintaining a Buy rating. This adjustment reflects an updated outlook from the analyst firm.

marketscreener.com · 2026-10-05 09:33 UTC

2026-09-18

UBS lowers Element Solutions stock price target on valuation

UBS lowered Element Solutions' price target to $47 citing valuation concerns despite strong electronics demand, following the termination of its merger with Solstice Advanced Materials.

Investing.com · 2026-09-18 13:45 UTC

2026-07-16

Shareholder Alert: M&A Class Action Firm Launches Legal Inquiry for Merger Involving ESI, CRNX, SOLS, and PATK

Monteverde & Associates PC initiated legal inquiries into proposed mergers for Element Solutions, Crinetics Pharmaceuticals, Solstice Advanced Materials, and Patrick Industries. Shareholders are encou

Sahm · 2026-07-16 07:10 UTC

Media coverage (4)

UBS Raises Price Target for Element Solutions Stock to USD 48AD HOC NEWS
UBS Adjusts Price Target on Element Solutions to $48 From $47, Keeps Buy Ratingmarketscreener.com
UBS lowers Element Solutions stock price target on valuationInvesting.com
Shareholder Alert: M&A Class Action Firm Launches Legal Inquiry for Merger Involving ESI, CRNX, SOLS, and PATKSahm